Intrinsic Therapeutics, Inc.
Barricaid is the only FDA-approved annular closure implant.
Following a lumbar discectomy, the Barricaid device is designed to close large defects (>5mm) in the annulus, which often lead to disc reherniation and/or disc collapse. Barricaid is a permanent implant with two components - an occlusion component and an anchor.
Brands: Barricaid Annular Closure